Price Set For COVID Drug Remdesivir
GILEAD SCIENCES HAS SET THE PRICES FOR ITS COVID-19 DRUG REMDESIVIR AS IT MOVES OUT OF ITS DONATION PERIOD
(CNN) – Gilead Sciences is setting prices for its COVID-19 drug Remdesivir as it moves out of its donation period.
It will be $390.00 per vial for some parts the US government, and for the governments of developed countries.
The company says Department of Veterans Affairs and Department of Defense Hospitals would get the discount, but it will not apply to Medicare or Medicaid.
The company says a typical five-day treatment course includes six vials, so the discounted price would be $2,340 per patient.
Meanwhile, the price for everyone else will be $520.00 per vial.
That adds up to $3,120 per patient for the same treatment course.
Until now, Remdesivir had been donated to the US government, with the last scheduled shipments going out Monday.
Remdesivir is currently administered intravenously through infusions.
It’s the only drug that has an emergency use authorization from the US Food and Drug Administration to treat coronavirus infections.